GB201800927D0

GB201800927D0 - Combination therapy for treating or preventing cancer

Combination therapy for treating or preventing cancer

Info

Publication number: GB201800927D0
Authority: GB; United Kingdom
Prior art keywords: treating; combination therapy; preventing cancer; cancer; preventing
Prior art date: 2018-01-19
Legal status : Ceased

Application number

GBGB1800927.4A

Current Assignee

4D Pharma Research Ltd

Original Assignee

4D Pharma Research Ltd

Priority date

2018-01-19

Filing date

2018-01-19

Publication date

2018-03-07

2018-01-19 Application filed by 4D Pharma Research Ltd filed Critical 4D Pharma Research Ltd

2018-01-19 Priority to GBGB1800927.4A priority Critical patent/GB201800927D0/en

2018-03-07 Publication of GB201800927D0 publication Critical patent/GB201800927D0/en

2019-01-18 Priority to JP2020537606A priority patent/JP2021510688A/en

2019-01-18 Priority to AU2019210003A priority patent/AU2019210003A1/en

2019-01-18 Priority to MX2020007681A priority patent/MX2020007681A/en

2019-01-18 Priority to MA051614A priority patent/MA51614A/en

2019-01-18 Priority to KR1020207021007A priority patent/KR20200110342A/en

2019-01-18 Priority to KR1020207021008A priority patent/KR20200110343A/en

2019-01-18 Priority to CA3088413A priority patent/CA3088413A1/en

2019-01-18 Priority to MA051613A priority patent/MA51613A/en

2019-01-18 Priority to TW108101920A priority patent/TW201938179A/en

2019-01-18 Priority to BR112020014565-3A priority patent/BR112020014565A2/en

2019-01-18 Priority to TW108101991A priority patent/TW201934139A/en

2019-01-18 Priority to CN201980009130.2A priority patent/CN111629739A/en

2019-01-18 Priority to SG11202006871YA priority patent/SG11202006871YA/en

2019-01-18 Priority to JP2020538852A priority patent/JP2021516662A/en

2019-01-18 Priority to MA051615A priority patent/MA51615A/en

2019-01-18 Priority to MX2020007665A priority patent/MX2020007665A/en

2019-01-18 Priority to CA3088343A priority patent/CA3088343A1/en

2019-01-18 Priority to SG11202006873UA priority patent/SG11202006873UA/en

2019-01-18 Priority to BR112020014676-5A priority patent/BR112020014676A2/en

2019-01-18 Priority to JP2020538811A priority patent/JP2021516661A/en

2019-01-18 Priority to PCT/GB2019/050143 priority patent/WO2019141998A1/en

2019-01-18 Priority to AU2019210002A priority patent/AU2019210002A1/en

2019-01-18 Priority to CN201980009092.0A priority patent/CN111902153A/en

2019-01-18 Priority to EP19703179.2A priority patent/EP3740220A1/en

2019-01-18 Priority to PCT/GB2019/050144 priority patent/WO2019141999A1/en

2019-01-18 Priority to CN201980009087.XA priority patent/CN111727047A/en

2019-01-18 Priority to SG11202006870XA priority patent/SG11202006870XA/en

2019-01-18 Priority to JP2020538821A priority patent/JP2021516216A/en

2019-01-18 Priority to EP19703178.4A priority patent/EP3740219A1/en

2019-01-18 Priority to MX2020007671A priority patent/MX2020007671A/en

2019-01-18 Priority to BR112020014595-5A priority patent/BR112020014595A2/en

2019-01-18 Priority to PCT/GB2019/050142 priority patent/WO2019141997A1/en

2019-01-18 Priority to CA3088333A priority patent/CA3088333A1/en

2019-01-18 Priority to KR1020207021009A priority patent/KR20200111183A/en

2019-01-18 Priority to CN201980009131.7A priority patent/CN111629740A/en

2019-01-18 Priority to KR1020207021004A priority patent/KR20200110341A/en

2019-01-18 Priority to CA3088338A priority patent/CA3088338A1/en

2019-01-18 Priority to AU2019210005A priority patent/AU2019210005A1/en

2019-01-18 Priority to TW108101942A priority patent/TW201938180A/en

2019-01-18 Priority to TW108101943A priority patent/TW201934138A/en

2019-01-18 Priority to BR112020014564-5A priority patent/BR112020014564A2/en

2019-01-18 Priority to EP19704381.3A priority patent/EP3740221A1/en

2019-01-18 Priority to SG11202006874SA priority patent/SG11202006874SA/en

2019-01-18 Priority to AU2019210004A priority patent/AU2019210004A1/en

2019-01-18 Priority to EP19701725.4A priority patent/EP3740218A1/en

2019-01-18 Priority to MX2020007664A priority patent/MX2020007664A/en

2019-01-18 Priority to MA051621A priority patent/MA51621A/en

2019-01-18 Priority to PCT/GB2019/050141 priority patent/WO2019141996A1/en

2020-07-05 Priority to IL275860A priority patent/IL275860A/en

2020-07-09 Priority to IL275949A priority patent/IL275949A/en

2020-07-15 Priority to PH12020551080A priority patent/PH12020551080A1/en

2020-07-15 Priority to IL276073A priority patent/IL276073A/en

2020-07-15 Priority to IL276074A priority patent/IL276074A/en

2020-07-16 Priority to US16/931,110 priority patent/US20210060093A1/en

2020-07-16 Priority to US16/931,104 priority patent/US20210060086A1/en

2020-07-17 Priority to US16/932,048 priority patent/US20210060094A1/en

2020-07-17 Priority to US16/932,052 priority patent/US20210060095A1/en

2020-07-17 Priority to CL2020001888A priority patent/CL2020001888A1/en

2020-07-17 Priority to NI202000052A priority patent/NI202000052A/en

2020-08-14 Priority to CONC2020/0010013A priority patent/CO2020010013A2/en

2022-09-30 Priority to US17/936,963 priority patent/US20230048366A1/en

2022-10-04 Priority to US17/937,819 priority patent/US20230277602A1/en

2023-02-15 Priority to US18/169,240 priority patent/US20240016861A1/en

Status Ceased legal-status Critical Current

Links

GBGB1800927.4A 2018-01-19 2018-01-19 Combination therapy for treating or preventing cancer Ceased GB201800927D0 (en)